The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
Diagnosis and Classification of Diabetes Mellitus
Open accessAbstract
DEFINITION AND DESCRIPTION OF DIABETES MELLITUSdDiabetes is a group of metabolic diseases characterized by hyperglycemia resulting from defects in insulin secretion, insulin action, or both. The chronic hyperglycemia of diabetes is associated with long-term damage, dysfunction, and failure of different organs, especially the eyes, kidneys, nerves, heart, and blood vessels. Several pathogenic processes are involved in the development of diabetes. These range from autoimmune destruction of the b-cells of the pancreas with consequent insulin deficiency to abnormalities that result in resistance to insulin action. The basis of the abnormalities in carbohydrate, fat, and protein metabolism in diabetes is deficient action of insulin on target tissues. Deficient insulin action results from inadequate insulin secretion and/or diminished tissue responses to insulin at one or more points in the complex pathways of hormone action. Impairment of insulin secretion and defects in insulin action frequently coexist in the same patient, and it is often unclear which abnormality, if either alone, is the primary cause of the hyperglycemia. Symptoms ofmarked hyperglycemia includepolyuria,polydipsia,weight loss,sometimes with polyphagia, and blurred vision. Impairment of growth and susceptibility to certain infections may also accompany chronic hyperglycemia. Acute, life-threatening consequences of uncontrolled diabetes are hyperglycemia with ketoacidosis or the nonketotic hyperosmolar syndrome. Long-term complications of diabetes include retinopathy with potential loss of vision; nephropathy leading to renal failure; peripheral neuropathy with risk of foot ulcers, amputations, and Charcot joints; and autonomic neuropathy causing gastrointestinal, genitourinary, and cardiovascular symptoms and sexual dysfunction. Patients with diabetes have an increased incidence of atherosclerotic cardiovascular, peripheral arterial, and cerebrovascular disease. Hypertension and abnormalities of lipoprotein metabolism are often found in people with diabetes. The vast majority of cases of diabetes fall into two broad etiopathogenetic categories (discussed in greater detail below). In one category, type 1 diabetes, the cause is an absolute deficiency of insulin secretion. Individuals at increased risk of developing this type of diabetes can often be identified by serological evidence of an autoimmune pathologic process occurring in the pancreatic islets and by genetic markers. In the other, much more prevalent category, type 2 diabetes, the cause is a combination of resistance to insulin action and an inadequate compensatory insulin secretory response. In the latter category, a degree of hyperglycemia sufficient to cause pathologic and functional changes in various target tissues, but without clinical symptoms, may be present for a long period of time before diabetes is detected. During this asymptomatic period, it is possible to demonstrate an abnormality in carbohydrate metabolism by measurement of plasma glucose in the fasting state or after a challenge with an oral glucose load. The degree of hyperglycemia (if any) may change over time, depending on the extent of the underlying disease process (Fig. 1). A disease process may be present but may not have progressed far enough to cause hyperglycemia. The same disease process can cause impaired fasting glucose (IFG) and/or impaired glucose tolerance (IGT) without fulfilling the criteria for the diagnosis of diabetes. In some individuals with diabetes, adequate glycemic control can be achieved with weight reduction, exercise, and/or oral glucoselowering agents. These individuals therefore do not require insulin. Other individuals who have some residual insulin secretion but require exogenous insulin for adequate glycemic control can survive without it. Individuals with extensive b-cell destruction and therefore no residual insulin secretion require insulin for survival. The severity of the metabolic abnormality can progress, regress, or stay the same. Thus, the degree of hyperglycemia reflects the severity of the underlying metabolic process and its treatment more than the nature of the process itself.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin
(2002) · New England Journal of Medicine · doi:10.1056/nejmoa012512 · Cited by 19,011
Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus
The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus (1997) · Diabetes Care · doi:10.2337/diacare.20.7.1183 · Cited by 6,220
Hyperglycemia and adverse pregnancy outcomes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0707943 · Cited by 5,563
Follow-up report on the diagnosis of diabetes mellitus
The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus* (2003) · Diabetes Care · doi:10.2337/diacare.26.11.3160 · Cited by 3,784
International Expert Committee report on the role of the A1c assay in the diagnosis of diabetes
The International Expert Committee (2009) · Diabetes Care · doi:10.2337/dc09-9033 · Cited by 3,185
Effect of Treatment of Gestational Diabetes Mellitus on Pregnancy Outcomes
Crowther, C. A., Hiller, J. E., Moss, J. R., McPhee, A. J., Jeffries, W. S., & Robinson, J. S. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa042973 · Cited by 3,159
A Multicenter, Randomized Trial of Treatment for Mild Gestational Diabetes
Landon, M. B., Spong, C. Y., Thom, E., Carpenter, M. W., Ramin, S. M., Casey, B., Wapner, R. J., Varner, M. W., Rouse, D. J., Thorp, J. M., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0902430 · Cited by 2,122 · cited 1×
“Expected benefits to their pregnancies and offspring is inferred from intervention trials that focused on women with more mild hyperglycemia than identified using older GDM diagnostic criteria and that found modest benefits (13,14).”
BackgroundMetzger, B. E., Gabbe, S. G., Persson, B., Lowe, L. P., Dyer, A. R., Oats, J. J. N., & Buchanan, T. A. (2010) · Diabetes Care · doi:10.2337/dc10-0719 · Cited by 1,888
Changes in incidence of diabetes in U.S. adults, 1997–2003
Geiss, L. S., Pan, L., Cadwell, B., Gregg, E. W., Benjamin, S. M., & Engelgau, M. M. (2006) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2005.12.009 · Cited by 229
Utility of hemoglobin A1c in predicting diabetes risk
Edelman, D., Olsen, M. K., Dudley, T. K., Harris, A. C., & Oddone, E. Z. (2004) · Journal of General Internal Medicine · doi:10.1111/j.1525-1497.2004.40178.x · Cited by 213
Cited by
Atkinson, M. A., Eisenbarth, G. S., & Michels, A. W. (2014) · The Lancet · doi:10.1016/s0140-6736(13)60591-7 · Cited by 2,931
Prevalence and Control of Diabetes in Chinese Adults
Xu, Y. (2013) · JAMA · doi:10.1001/jama.2013.168118 · Cited by 2,703
Standards of Medical Care in Diabetes—2012
(2012) · Diabetes Care · doi:10.2337/dc12-s011 · Cited by 2,240
Davies, M. J., Bergenstal, R., Bode, B., Kushner, R. F., Lewin, A., Skjøth, T. V., Andreasen, A. H., Jensen, C. B., DeFronzo, R. A., & for the NN8022-1922 Study Group (2015) · JAMA · doi:10.1001/jama.2015.9676 · Cited by 1,198
Predicting Diabetes Mellitus With Machine Learning Techniques
Zou, Q., Qu, K., Luo, Y., Yin, D., Ju, Y., & Tang, H. (2018) · Frontiers in Genetics · doi:10.3389/fgene.2018.00515 · Cited by 920
Definition, Classification and Diagnosis of Diabetes, Prediabetes and Metabolic Syndrome
Punthakee, Z., Goldenberg, R., & Katz, P. (2018) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2017.10.003 · Cited by 877
Ma, R. C. W., & Chan, J. C. N. (2013) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12098 · Cited by 827
Nilwik, R., Snijders, T., Leenders, M., Groen, B. B. L., van Kranenburg, J., Verdijk, L. B., & van Loon, L. J. C. (2013) · Experimental Gerontology · doi:10.1016/j.exger.2013.02.012 · Cited by 776
Schouten, J., Wit, F. W., Stolte, I. G., Kootstra, N. A., van der Valk, M., Geerlings, S. E., Prins, M., Reiss, P., for the AGEhIV Cohort Study Group, Reiss, P., et al. (2014) · Clinical Infectious Diseases · doi:10.1093/cid/ciu701 · Cited by 752
Gestational Diabetes Mellitus: Risks and Management during and after Pregnancy
Buchanan, T. A., Xiang, A. H., & Page, K. A. (2012) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2012.96 · Cited by 718
Association of Weight Status With Mortality in Adults With Incident Diabetes
Carnethon, M. R., De Chavez, P. J. D., Biggs, M. L., Lewis, C. E., Pankow, J. S., Bertoni, A. G., Golden, S. H., Liu, K., Mukamal, K. J., Campbell-Jenkins, B., et al. (2012) · JAMA · doi:10.1001/jama.2012.9282 · Cited by 567
Dunkley, A. J., Bodicoat, D. H., Greaves, C. J., Russell, C., Yates, T., Davies, M. J., & Khunti, K. (2014) · Diabetes Care · doi:10.2337/dc13-2195 · Cited by 542
Schellenberg, E. S., Dryden, D. M., Vandermeer, B., Ha, C., & Korownyk, C. (2013) · Annals of Internal Medicine · doi:10.7326/0003-4819-159-8-201310150-00007 · Cited by 520
Markers of Oxidative Stress during Diabetes Mellitus
Tiwari, B. K., Pandey, K. B., Abidi, A. B., & Rizvi, S. I. (2013) · Journal of Biomarkers · doi:10.1155/2013/378790 · Cited by 517
Kulik, A., Ruel, M., Jneid, H., Ferguson, T. B., Hiratzka, L. F., Ikonomidis, J. S., Lopez-Jimenez, F., McNallan, S. M., Patel, M., Roger, V. L., et al. (2015) · Circulation · doi:10.1161/cir.0000000000000182 · Cited by 448
Analysis of diabetes mellitus for early prediction using optimal features selection
Sneha, N., & Gangil, T. (2019) · Journal of Big Data · doi:10.1186/s40537-019-0175-6 · Cited by 407
Kim, Y. G., Hahn, S., Oh, T. J., Kwak, S. H., Park, K. S., & Cho, Y. M. (2013) · Diabetologia · doi:10.1007/s00125-012-2827-3 · Cited by 396
Asemi, Z., Zare, Z., Shakeri, H., Sabihi, S.-S., & Esmaillzadeh, A. (2013) · Annals of Nutrition and Metabolism · doi:10.1159/000349922 · Cited by 392
Steroid‐induced diabetes: a clinical and molecular approach to understanding and treatment
Hwang, J. L., & Weiss, R. E. (2014) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2486 · Cited by 380
Wakabayashi, I., & Daimon, T. (2015) · Clinica Chimica Acta · doi:10.1016/j.cca.2014.08.042 · Cited by 377
Melatonin secretion and the incidence of type 2 diabetes
McMullan, C. J., Schernhammer, E. S., Rimm, E. B., Hu, F. B., & Forman, J. P. (2013) · JAMA · doi:10.1001/jama.2013.2710 · Cited by 369
Karstoft, K., Winding, K., Knudsen, S. H., Nielsen, J. S., Thomsen, C., Pedersen, B. K., & Solomon, T. P. J. (2013) · Diabetes Care · doi:10.2337/dc12-0658 · Cited by 339
In-vitro alpha amylase inhibitory activity of the leaf extracts of Adenanthera pavonina
Wickramaratne, M. N., Punchihewa, J. C., & Wickramaratne, D. B. M. (2016) · BMC Complementary and Alternative Medicine · doi:10.1186/s12906-016-1452-y · Cited by 337
Racial/ethnic differences in dyslipidemia patterns
Frank, A. T. H., Zhao, B., Jose, P. O., Azar, K. M. J., Fortmann, S. P., & Palaniappan, L. P. (2014) · Circulation · doi:10.1161/circulationaha.113.005757 · Cited by 327
Adeel, M., Rahman, M. M., Caligiuri, I., Canzonieri, V., Rizzolio, F., & Daniele, S. (2020) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2020.112331 · Cited by 327
Olbers, T., Beamish, A. J., Gronowitz, E., Flodmark, C.-E., Dahlgren, J., Bruze, G., Ekbom, K., Friberg, P., Göthberg, G., Järvholm, K., et al. (2017) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(16)30424-7 · Cited by 318
Ziegler, D., Papanas, N., Zhivov, A., Allgeier, S., Winter, K., Ziegler, I., Brüggemann, J., Strom, A., Peschel, S., Köhler, B., et al. (2014) · Diabetes · doi:10.2337/db13-1819 · Cited by 313
Diabetes-induced hyperglycemia impairs male reproductive function: A systematic review
Maresch, C. C., Stute, D. C., Alves, M. G., Oliveira, P. F., de Kretser, D. M., & Linn, T. (2018) · Human Reproduction Update · doi:10.1093/humupd/dmx033 · Cited by 294
Association of diabetes and tuberculosis: impact on treatment and post-treatment outcomes
Jiménez-Corona, M. E., Cruz-Hervert, L. P., García-García, L., Ferreyra-Reyes, L., Delgado-Sánchez, G., Bobadilla-del-Valle, M., Canizales-Quintero, S., Ferreira-Guerrero, E., Báez-Saldaña, R., Téllez-Vázquez, N., et al. (2013) · Thorax · doi:10.1136/thoraxjnl-2012-201756 · Cited by 294
Recent updates on GLP-1 agonists: Current advancements & challenges
Sharma, D., Verma, S., Vaidya, S., Kalia, K., & Tiwari, V. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.08.088 · Cited by 265
A thrifty variant in CREBRF strongly influences body mass index in Samoans
Minster, R. L., Hawley, N. L., Su, C.-T., Sun, G., Kershaw, E. E., Cheng, H., Buhule, O. D., Lin, J., Reupena, M. S., Viali, S., et al. (2016) · Nature Genetics · doi:10.1038/ng.3620 · Cited by 262
Resveratrol: review on therapeutic potential and recent advances in drug delivery
Pangeni, R., Sahni, J. K., Ali, J., Sharma, S., & Baboota, S. (2014) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2014.919253 · Cited by 255
Rickels, M. R., Bellin, M., Toledo, F. G. S., Robertson, R. P., Andersen, D. K., Chari, S. T., Brand, R., Frulloni, L., Anderson, M. A., & Whitcomb, D. C. (2013) · Pancreatology · doi:10.1016/j.pan.2013.05.002 · Cited by 249
Writing Committee for the Type 1 Diabetes TrialNet Oral Insulin Study Group, Krischer, J. P., Schatz, D. A., Bundy, B., Skyler, J. S., & Greenbaum, C. J. (2017) · JAMA · doi:10.1001/jama.2017.17070 · Cited by 214
Kempf, T., Guba-Quint, A., Torgerson, J., Magnone, M. C., Haefliger, C., Bobadilla, M., & Wollert, K. C. (2012) · European Journal of Endocrinology · doi:10.1530/eje-12-0466 · Cited by 176
Gunderson, E. P., Lewis, C. E., Lin, Y., Sorel, M., Gross, M., Sidney, S., Jacobs, D. R., Shikany, J. M., & Quesenberry, C. P. (2018) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2017.7978 · Cited by 164
Jung, M. E., Bourne, J. E., Beauchamp, M. R., Robinson, E., & Little, J. P. (2015) · Journal of Diabetes Research · doi:10.1155/2015/191595 · Cited by 165
Hanslik, G., Wallaschofski, H., Dietz, A., Riester, A., Reincke, M., Allolio, B., Lang, K., Quack, I., Rump, L. C., Willenberg, H. S., et al. (2015) · European Journal of Endocrinology · doi:10.1530/eje-15-0450 · Cited by 155
Shakeri, H., Hadaegh, H., Abedi, F., Tajabadi‐Ebrahimi, M., Mazroii, N., Ghandi, Y., & Asemi, Z. (2014) · Lipids · doi:10.1007/s11745-014-3901-z · Cited by 145
Guo, F., Moellering, D. R., & Garvey, W. T. (2014) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2013.0128 · Cited by 139
Nikbakht, E., Khalesi, S., Singh, I., Williams, L. T., West, N. P., & Colson, N. (2018) · European Journal of Nutrition · doi:10.1007/s00394-016-1300-3 · Cited by 126
Novel views on new-onset diabetes after transplantation: development, prevention and treatment
Hecking, M., Werzowa, J., Haidinger, M., Horl, W. H., Pascual, J., Budde, K., Luan, F. L., Ojo, A., de Vries, A. P. J., Porrini, E., et al. (2013) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfs583 · Cited by 120
Asemi, Z., Samimi, M., Tabassi, Z., & Esmaillzadeh, A. (2014) · European Journal of Clinical Nutrition · doi:10.1038/ejcn.2013.296 · Cited by 119
Hackett, R. A., Kivimäki, M., Kumari, M., & Steptoe, A. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-2853 · Cited by 121
Association of Diurnal Patterns in Salivary Cortisol With Type 2 Diabetes in the Whitehall II Study
Hackett, R. A., Steptoe, A., & Kumari, M. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-2459 · Cited by 118
SIRT1, p66Shc, and Set7/9 in Vascular Hyperglycemic Memory
Paneni, F., Volpe, M., Lüscher, T. F., & Cosentino, F. (2013) · Diabetes · doi:10.2337/db12-1648 · Cited by 118
Selective insulin resistance with differential expressions of IRS-1 and IRS-2 in human NAFLD livers
Honma, M., Sawada, S., Ueno, Y., Murakami, K., Yamada, T., Gao, J., Kodama, S., Izumi, T., Takahashi, K., Tsukita, S., et al. (2018) · International Journal of Obesity · doi:10.1038/s41366-018-0062-9 · Cited by 108
Disease Management Programs for Type 2 Diabetes in Germany
Fuchs, S., Henschke, C., Blümel, M., & Busse, R. (2014) · Deutsches Ärzteblatt international · doi:10.3238/arztebl.2014.0453 · Cited by 102
Low-Carbohydrate Diet for the Treatment of Gestational Diabetes Mellitus
Moreno-Castilla, C., Hernandez, M., Bergua, M., Alvarez, M. C., Arce, M. A., Rodriguez, K., Martinez-Alonso, M., Iglesias, M., Mateu, M., Santos, M. D., et al. (2013) · Diabetes Care · doi:10.2337/dc12-2714 · Cited by 97
Diagnosis and complications of Cushing’s disease: gender-related differences
Zilio, M., Barbot, M., Ceccato, F., Camozzi, V., Bilora, F., Casonato, A., Frigo, A. C., Albiger, N., Daidone, V., Mazzai, L., et al. (2014) · Clinical Endocrinology · doi:10.1111/cen.12299 · Cited by 93
Aging, Diabetes, and Hypertension Are Associated With Decreased Nasal Mucociliary Clearance
Proença de Oliveira-Maul, J., Barbosa de Carvalho, H., Goto, D. M., Maia, R. M., Fló, C., Barnabé, V., Franco, D. R., Benabou, S., Perracini, M. R., Jacob-Filho, W., et al. (2013) · Chest · doi:10.1378/chest.12-1183 · Cited by 93
Monlezun, D. J., Kasprowicz, E., Tosh, K. W., Nix, J., Urday, P., Tice, D., Sarris, L., & Harlan, T. S. (2015) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2015.05.007 · Cited by 76
Bailey, K. J., Little, J. P., & Jung, M. E. (2016) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2015.0285 · Cited by 70
Asbaghi, O., Nazarian, B., Yousefi, M., Anjom-Shoae, J., Rasekhi, H., & Sadeghi, O. (2023) · Nutrition Journal · doi:10.1186/s12937-023-00840-1 · Cited by 68
Demakakos, P., Zaninotto, P., & Nouwen, A. (2014) · Psychosomatic Medicine · doi:10.1097/psy.0000000000000082 · Cited by 58
Selective rather than universal screening for gestational diabetes mellitus?
Miailhe, G., Kayem, G., Girard, G., Legardeur, H., & Mandelbrot, L. (2015) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2015.05.003 · Cited by 51
Li, Y., Storch, E. A., Ferguson, S., Li, L., Buys, N., & Sun, J. (2022) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2022.109965 · Cited by 47
Usami, T., Yokoyama, M., Ueno, M., Iwama, N., Sagawa, N., Kawano, R., Waguri, M., Sameshima, H., Hiramatsu, Y., Sugiyama, T., et al. (2020) · Journal of Diabetes Investigation · doi:10.1111/jdi.13101 · Cited by 44
Improved diastolic function in type 2 diabetes after a six month liraglutide treatment
Saponaro, F., Sonaglioni, A., Rossi, A., Montefusco, L., Lombardo, M., Adda, G., & Arosio, M. (2016) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2016.04.046 · Cited by 41
Wang, J.-F., Zhang, H.-M., Li, Y.-Y., Xia, S., Wei, Y., Yang, L., Wang, D., Ye, J.-J., Li, H.-X., Yuan, J., et al. (2019) · Lipids in Health and Disease · doi:10.1186/s12944-019-1048-x · Cited by 38
Wang, B., Wang, Z., Poundarik, A. A., Zaki, M. J., Bockman, R. S., Glicksberg, B. S., Nadkarni, G. N., & Vashishth, D. (2022) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab882 · Cited by 37
Kyozuka, H., Yasuda, S., Murata, T., Fukuda, T., Yamaguchi, A., Kanno, A., Sato, A., Ogata, Y., Hosoya, M., Yasumura, S., et al. (2021) · Journal of Diabetes Investigation · doi:10.1111/jdi.13569 · Cited by 37
Gestational diabetes and macrosomia by race/ethnicity in Hawaii
Tsai, P.-J. S., Roberson, E., & Dye, T. (2013) · BMC Research Notes · doi:10.1186/1756-0500-6-395 · Cited by 30
Kuramitsu, S., Yokoi, H., Domei, T., Nomura, A., Watanabe, H., Yamaji, K., Soga, Y., Arita, T., Kondo, K., Shirai, S., et al. (2013) · Cardiovascular Diabetology · doi:10.1186/1475-2840-12-74 · Cited by 26
Maternal–Foetal Diabetes Modifies Neonatal Fc Receptor Expression on Human Leucocytes
de Souza, E. G., Hara, C. C. P., Fagundes, D. L. G., de Queiroz, A. A., Morceli, G., Calderon, I. M. P., França, E. L., & Honorio‐França, A. C. (2016) · Scandinavian Journal of Immunology · doi:10.1111/sji.12466 · Cited by 22
Rockette-Wagner, B., Storti, K. L., Dabelea, D., Edelstein, S., Florez, H., Franks, P. W., Montez, M. G., Pomeroy, J., & Kriska, A. M. (2017) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2016.10.007 · Cited by 21
Oh, T. J., Kim, Y. G., Kang, S., Moon, J. H., Kwak, S. H., Choi, S. H., Lim, S., Park, K. S., Jang, H. C., Hong, J.-S., et al. (2019) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2018.0086 · Cited by 17
Mendez-Figueroa, H., Daley, J., Lopes, V. V., & Coustan, D. R. (2013) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.3109/14767058.2013.780594 · Cited by 10
Thomaseth, K., Brehm, A., Pavan, A., Pacini, G., & Roden, M. (2014) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00314.2013 · Cited by 9
Prevalence of gestational diabetes in the southern part of Bosnia and Herzegovina
Tomic, V., Misic, M., Simic, A., Boskovic, A., Kresic, T., Peric, O., Orlovic, M., & Blagojevic, A. (2016) · Materia Socio Medica · doi:10.5455/msm.2016.28.329-332 · Cited by 1
Metadata
- Authors
- American Diabetes Association
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2011-12-13
- Volume
- 35
- Issue
- Supplement_1
- Pages
- S64-S71
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- OpenAlex
- W4232215346
- Cited by
- 1,491
- References
- 14
- FWCI
- 106.62
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.